2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 33154093 | Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents. | 2021 Feb | 1 |
| 2 | 33148342 | XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53. | 2020 Nov 4 | 1 |